Burns also noted that in 2024, Wegovy, Zepbound, and Ozempic had nearly half a billion dollars in advertising behind them, and asked a fair question: if these drugs work so well, why the need to market them so aggressively
These 6 deaths occurred in 1 patient who received tirzepatide at a dose of 5 mg, 2 patients who received tirzepatide at a dose of 10 mg, 2 patients (including the patient with presumptive Covid-19) who received tirzepatide at a dose of 15 mg, and 1 patient who received semaglutide
Your Next Steps If you think you might meet GLP-1 eligibility criteria, here's how to move forward: Schedule a consultation with a healthcare provider experienced in weight management and metabolic health
At the same time, theres a lot of confusion online
Many patients see improvements in blood sugar and cardiovascular markers as they lose weight